Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Expand chart
Data: Our World in Data; Chart: Danielle Alberti/Axios

The world reached a vaccination milestone this week, with 2 billion total doses now administered, according to the tracker from Our World in Data.

Why it matters: The global rate is speeding up considerably. It took 30 days to go from 500 million doses to 1 billion, 24 days to go from 1 billion to 1.5 billion, and just 16 days to jump from 1.5 billion to 2 billion.

  • But the vast majority of those vaccinations are still coming in the countries or regions that are either producing vaccines at scale (China, India, U.S., EU) or could afford to buy their way to the front of the line.

Breaking it down: High-income countries (as defined by the World Bank) are generally far ahead of the pack, with a combined 16% of the world's population but 38% of all vaccinations.

  • But even among the wealthy, progress is uneven. 58% of Brits have had at least one dose, for example, versus just 13% of South Koreans and 9% in Japan.
  • Meanwhile, low-income countries are almost all struggling, with 9% of the world's population but 0.3% of vaccinations. Sub-Saharan Africa is the furthest behind (see chart).

That gulf in supply has been exacerbated by the fact that the COVAX initiative — on which many low- and middle-income countries are relying — is running months behind schedule.

  • Efforts to expand manufacturing capacity, particularly in the developing world, could help close the gap over time. But for now, attention is falling on the rich countries that have purchased far more than they need.
  • President Biden will likely leverage the White House announcement today on dose sharing (see item 2) to lobby other rich countries to increase their pledges, including at the upcoming G7 summit.
  • The EU, for example, has promised to donate 100 million doses by the end of the year, but has offered little in the short term.

What to watch: Some low-income countries like the Democratic Republic of the Congo — which recently returned 1.3 million doses that were at risk of expiring — have struggled to administer the few doses they have obtained.

  • The challenges include training and deploying health workers, transporting vaccines where they're needed — door to door if necessary — and communicating effectively about the benefits of vaccination.
  • As access to vaccines finally starts to increase in the developing world, more global attention and resources will have to be committed to the delivery phase. The World Bank has started funding some of those efforts.

Worth noting: China has nearly tripled its daily vaccination rate over the past month, according to Our World in Data, and it's now giving more shots per day (19.7 million) than all but 14 other countries have over the entirety of the pandemic.

Go deeper

Sep 10, 2021 - Health

FDA "will follow the science" to approve COVID vaccine for kids under 12

A nurse gives a boy a dose of the Pfizer vaccine at a clinic. Photo: Paul Hennessy/SOPA Images/LightRocket via Getty Images

The FDA said on Friday that it is "working around the clock" to support the process of making the coronavirus vaccine available for children under the age of 12.

Why it matters: The number of children getting hospitalized due to the virus is increasing, with some infectious disease doctors worrying that the Delta variant could be causing more serious illness in kids.

Sep 10, 2021 - Politics & Policy

Former FDA chief: U.S. has to continue to "chip away" at new vaccinations

Screenshot: Axios

The U.S. will have to find new ways to get unvaccinated Americans inoculated against the coronavirus to curb the pandemic, former FDA commissioner Scott Gottlieb said during an Axios virtual event on Friday.

Why it matters: President Biden announced several efforts to boost new vaccinations, including requiring more than 80 million Americans working in the private sector to receive a COVID-19 vaccine or produce a negative test result at least once a week.

Sep 11, 2021 - World

France grants citizenship to 12,000 COVID frontline workers

A nurse takes care of a patient infected with COVID in the intensive care unit of Lyon-Sud Hospital in Pierre-Bénite, France. Photo: Jeff Pachoud/AFP via Getty Images

France granted citizenship to 12,000 COVID frontline workers this week in a show of gratitude for their efforts and sacrifices.

Why it matters: Immigrants comprise a quarter of the essential workers who remained active in the Île-de-France province during lockdowns, per data from a French health observatory.